Dear users,
DigiFinex will list CUDIS (CUDIS). The specific schedule is as follows:
Trading pair: CUDIS/USDT
Token Introduction:
Aiming to extend the health-span to 140 years, CUDIS is building the first-ever Longevity protocol, designed to make longevity trackable, personalized, and rewarding. Through the integration of the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users gain full ownership of their health data, real-time longevity insights, and economic incentives for optimizing their biological health. CUDIS is building a new longevity ecosystem with realistic and effective products, programs and services with partners around the world.
Download DigiFinex APP: https://www.digifinex.com/en-ww/download
Official Register link: https://www.digifinex.com/en-ww/from/C9JT9c?channelCode=ljaUPp
Disclaimer:
Cryptocurrencies inherently come with market risks and volatility, despite their potential for high growth. We strongly advise users to conduct their research as they invest, acknowledging that they do so at their own risk. Your support for DigiFinex is appreciated!
Canadian Market Disclaimer:
The products mentioned is not eligible for the Canadian market in line with the Pre-Registration Undertaking applicable to DigiFinex. Where technologically feasible, DigiFinex has implemented measures to avoid the dissemination of relevant promotional material to Ips originating from within Canada (apply to all new listings and products except BTC/ETH vs Fiat/USDC pairings).
Thank you for your support!
DigiFinex Team
Jan. 15th, 2026
DigiFinex communities：
Telegram Official Community:https://t.me/DigiFinexEN
Official Twitter: https://twitter.com/digifinex
Official Facebook:https://www.facebook.com/digifinex.global
Official Instagram:https://www.instagram.com/digifinex.global
Official Medium: https://medium.com/@digifinex
Official Reddit: https://www.reddit.com/user/DigiFinex/
DigiFinex (digifinex.com) DIGIFINEX LIMITED reserves all rights of this event, including but not limited to adjustment, explanation, and termination at any time.
Comments
0 comments
Article is closed for comments.